Study: Comorbid Arthritis Associated with Lower Health-Related Quality of Life in Older Adults
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Humana (HUM) PT Raised to $230 at Cantor Fitzgerald Following 2Q Release
August 2, 2017 1:17 PM EDTCantor Fitzgerald raised its price target on Humana (NYSE: HUM) to $230.00 (from $200.00) while maintaining a Neutral rating following the company's 2Q earnings report. Non-GAAP EPS was $3.49 vs. recast 2Q16 nonGAAP EPS of $3.29. Medicare revenue grew 3.3% y/y compared to 1.2% in 1Q17.
The company... More
